2 most recent filings and news items mentioning INM. Updated every 60 seconds.
curl "https://api.brieftape.com/v1/tickers/INM/news?limit=20"
Pull INM filings straight into your trading bot, model, or app.
Get an API key — free tier: 10,000 calls/dayInMed Pharmaceuticals filed an amendment to its previously signed merger agreement with Mentari Therapeutics, Inc. This document confirms the approval of the transaction by the relevant boards of directors for Parent and Merger Subs.
View filing at SEC.gov →InMed Pharmaceuticals has regained compliance with Nasdaq's minimum bid price requirement of $1.00 per share after its stock traded at or above that level for 10 consecutive business days. The company had been notified of non-compliance on March 27, 2026, but successfully remedie
View filing at SEC.gov →